Ronald Kamdem
Stock Analyst at Morgan Stanley
(1.08)
# 1765
Out of 5,326 analysts
202
Total ratings
48.98%
Success rate
-5.57%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CURB Curbline Properties | Maintains: Equal-Weight | 27 26 | 23.04 | 12.85% | 2 | Apr 24, 2025 | |
CBRE CBRE Group | Maintains: Overweight | 165 160 | 122.88 | 30.21% | 4 | Apr 24, 2025 | |
MAC Macerich | Maintains: Equal-Weight | 20 19 | 14.66 | 29.6% | 2 | Apr 1, 2025 | |
LINE Lineage | Maintains: Overweight | 80 75 | 56.38 | 33.03% | 2 | Apr 1, 2025 | |
AHR American Healthcare ... | Maintains: Overweight | 36 37 | 31.05 | 19.16% | 4 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 5 4 | 4.33 | -7.62% | 6 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 3 3 | 2.24 | 0.45% | 10 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 26 28 | 35.51 | -21.15% | 7 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 53 53 | 49.08 | 7.99% | 4 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 23 22 | 12.46 | 76.57% | 2 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 25 | 22.38 | 11.71% | 1 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 293 315 | 293.89 | 7.18% | 17 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 132 133 | 103.45 | 28.56% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Equal-Weight | 62 | 57.2 | 8.39% | 7 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 103 108 | 147.81 | -27.27% | 5 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 33 33 | 32.47 | 1.63% | 4 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 9 7 | 7.36 | -4.89% | 1 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 2 2 | 0.4 | 300% | 15 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 18 21 | 28.29 | -25.77% | 10 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 143 145 | 156.43 | -7.31% | 3 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 14 18 | 18.37 | -2.01% | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 62 75 | 71.48 | 4.92% | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 115 150 | 141.91 | 5.7% | 20 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 42 32 | 36.46 | -12.23% | 20 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 45 47 | 68.46 | -31.35% | 3 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 40 40 | n/a | n/a | 5 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 30 24 | 14.79 | 58.89% | 7 | Jul 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 38 35 | 54.6 | -35.9% | 5 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 68 67 | 66.09 | 1.38% | 6 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 20 19 | 15.95 | 19.12% | 6 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 25 26 | n/a | n/a | 5 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 45 46 | 40.97 | 12.28% | 6 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 77 73 | 76.36 | -4.4% | 3 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 195 150 | 162.78 | -7.85% | 1 | Oct 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 41 48 | n/a | n/a | 1 | Jun 3, 2021 |